Specifically, the elevated production of chemokines, metabolites, and growth factors (e.g., IL-6, TGF-β, VEG-F, etc.)by tumor-induced immune cells can cause systemic changes that promote suppression of adaptive immunity (53–58). The gene discussed is TGFB1; the disease is neoplasm.